Biotechnology News and Research

RSS

New Wilmot Cancer Center offers expanded care, research for cures

The University of Rochester Medical Center (URMC) today celebrates the expansion of cancer care and research as it dedicates the new James P. Wilmot Cancer Center. The Center introduces leading-edge technology, greater access to multidisciplinary care, a new model for breast care, and more opportunities to receive tomorrow's therapies today.

15 May 2008

Researchers who helped millions with arthritis receive Janssen Award

Two British researchers who pioneered treatments which have helped millions of people with rheumatoid arthritis and other autoimmune diseases have been awarded the prestigious 2008 Dr. Paul Janssen Award for Biomedical Research, announced today.

13 May 2008

Scientists publish guidelines for the improved description of genomes and metagenomes

The Genomic Standards Consortium (GSC), an international initiative including representatives from a range of major sequencing and bioinformatics centres, has created a new guideline for describing genomes and metagenomes. The guideline, 'Minimum Information about a Genome Sequence' (MIGS), is published in the May issue of the journal Nature Biotechnology.

12 May 2008

Human aging gene found in flies

Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have found a fast and effective way to investigate important aspects of human ageing.

11 May 2008

Cytopia announces novel anti-cancer drug development collaboration

Cytopia Limited today announced that it has entered into an anti-cancer drug discovery and development collaboration with Cancer Therapeutics CRC Pty Ltd. This agreement leverages Cytopia's early stage drug discovery pipeline of kinase inhibitors, a class of targeted therapeutics that is one of the fastest growing segments of the cancer drug market.

9 May 2008

GeoVax Labs to launch phase II trials of HIV vaccine candidate

The Atlanta-based biotechnology firm GeoVax Labs plans to launch Phase II clinical trials of its experimental HIV vaccine this summer, company officials recently announced, the Atlanta Journal-Constitution reports (Hendrick, Atlanta Journal-Constitution, 5/8).

8 May 2008

Biosimilar protein cooperation

A biosimilar protein that can be used to treat neutropenia (a side effect of cancer chemotherapy) is to be developed by Apotex Inc. of Canada in collaboration with Intas Biopharmaceuticals Limited (IBPL).

6 May 2008

Prana Biotechnology has discovered novel drug candidates for use in Parkinson's disease

Prana Biotechnology Limited has announced that it has identified novel therapeutic drug candidates from its Parkinson's disease program. Already, a lead candidate drug has demonstrated positive effects in pre-clinical studies, protecting the brain from damage to the substantia nigra, the area of the brain affected in Parkinson's disease.

6 May 2008

Forty-one percent of registered nurses find generics are less effective than name brand drugs say American Society of Registered Nurses

In a national online survey conducted by the American Society of Registered Nurses, 41% of the 781 Registered Nurses surveyed on April 28 reported that generic drugs are less effective than their equivalent brand-name counterparts.

5 May 2008

Researchers report the cloning of a key group of human genes, the protein kinases

Although the human genome has been sequenced, research into mechanism of action of genes has been hampered by the fact that most human genes have not been isolated.

2 May 2008

Novavax opens new U.S. vaccine plant in Rockville, Maryland

Officials from Novavax, Inc., the State of Maryland and Montgomery County today celebrated the opening of Novavax's new state-of-the-art vaccine production facility at the company's headquarters in Rockville, Maryland.

1 May 2008

New understanding of how some bacteria survive antibiotic treatment

Researchers at the University of Illinois at Chicago have discovered how some bacteria can survive antibiotic treatment by turning on resistance mechanisms when exposed to the drugs.

30 Apr 2008

First sequence-based map of large-scale structural variation across the human genome

A nationwide team of researchers, funded in part by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has produced the first sequence-based map of large-scale structural variation across the human genome. The work, published today in the journal Nature, provides a starting point to examine how such DNA variation contributes to human health and disease.

30 Apr 2008

CSIRO researchers open up new class of chemistry

CSIRO Entomology business manager, Cameron Begley, said researchers believed the discovery opened up an entirely new class of chemistry.

29 Apr 2008

Newly refined antibody therapy may be potent treatment for autoimmune diseases

An old, fickle therapy for a variety of autoimmune diseases is getting a makeover, thanks to a decade-long investigation by Rockefeller University researchers.

26 Apr 2008

Bioartificial kidney speeds recovery, reduces mortality

Another promising clinical trial for the bioartificial kidney is offering researchers even more hope that within the next few years the device will be available to save lives of patients with acute renal failure.

24 Apr 2008

Researchers unravel heparin death mystery

An international team of researchers led by MIT has explained how contaminated batches of the blood-thinner heparin were able to slip past traditional safety screens and kill dozens of patients recently in the United States and Germany.

23 Apr 2008

Biopharmaceutical spin-out company Domainex, secures funding

Headquartered in London, Domainex is a contract research company specialising in the provision of structural biology and chemistry services to major pharmaceutical and biotechnology firms. The Company is also developing a pipeline of pre-clinical drugs and targets.

From Domainex 23 Apr 2008

Different processes govern sight, light detection - findings could point toward help for SAD, insomnia patients

A Johns Hopkins University biologist, in research with implications for people suffering from seasonal affective disorder and insomnia, has determined that the eye uses light to reset the biological clock through a mechanism separate from the ability to see.

23 Apr 2008

Discovery of gene that may influence metastasis risk in breast cancer

Researchers have identified a pattern of gene activity in mice that may help to predict individual risk for breast cancer metastasis and survival in humans. A single gene, called bromodomain 4 (Brd4), regulates the expression of this pattern, also called a signature.

22 Apr 2008